niacinamide has been researched along with bms345541 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, F; Richmond, A; Smykla, R; Thu, YM; Yang, J; Zaja-Milatovic, S | 1 |
Buhrmann, C; Busch, F; Shakibaei, M; Shayan, P | 1 |
2 other study(ies) available for niacinamide and bms345541
Article | Year |
---|---|
Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Biomarkers, Tumor; Dacarbazine; Drug Delivery Systems; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Niacinamide; Phenylurea Compounds; Pyridines; Quinoxalines; Skin Neoplasms; Sorafenib; Substrate Specificity; Temozolomide; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |
Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells.
Topics: Acetylation; Cell Differentiation; Cells, Cultured; Chondrocytes; Chondrogenesis; Enzyme Activation; Enzyme Inhibitors; Gene Knockdown Techniques; Humans; I-kappa B Kinase; Imidazoles; Interleukin-1beta; Mesenchymal Stem Cells; NF-kappa B; Niacinamide; Quinoxalines; Resveratrol; Signal Transduction; Sirtuin 1; SOX9 Transcription Factor; Stilbenes | 2014 |